Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Atrial Fibrillation Surgery Market was valued at USD 1,026.99 million in 2016 and is projected to reach USD 3,797.26 million by 2025, growing at a CAGR of 13.97% from 2017 to 2025.
The Atrial fibrillation surgery occurrence is becoming more frequent because of increasing geriatric population, also because of lifestyle changes in the young population. The efficiency of the surgeries is main factor considered to increase the growth of the market.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population
1.2 Technological advancements
1.3 Rising occurrence of diseases caused by lifestyle habits
1.4 Increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery
2. Market Restraints
2.1 High cost of healthcare
Market Segmentation:
1. Global Atrial Fibrillation Surgery Market, by Procedure:
1.1 Catheter Ablation Procedures
1.2 Surgical Ablation/Maze Procedures
2. Global Atrial Fibrillation Surgery Market, by Product:
2.1 Catheter Ablation Product Market
2.2 Surgical Ablation Market
3. Global Atrial Fibrillation Surgery Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Biosense Webster, Inc.
2. Medtronic, Inc.
3. St. Jude Medical, Inc.
4. Boston Scientific Corporation
5. Atricure, Inc.
6. Cardiofocus, Inc.
7. Ncontact, Inc.
8. Carima, Inc.
9. Biotroik Se & Co.Kg
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Atrial Fibrillation Surgery Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.